Unither acquires Creapharm SAS from PCAS


FRANCE - Unither acquired a ##% interest, in Creapharm SAS, a Longjuheau-based manufacturer of prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics, from Produits Chimiques Auxiliaires et de Synthese {PCAS}. Terms were not disclosed.

Deal Information

Credit & Investment Research

Market Research

News